MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
-49.4%/yr
Quarterly compound
Percentile
P65
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.47% |
| Q3 2025 | -26.27% |
| Q2 2025 | -38.24% |
| Q1 2025 | 12.41% |
| Q4 2024 | -28.86% |
| Q3 2024 | -45.84% |
| Q2 2024 | -77.48% |
| Q1 2024 | -83.85% |
| Q4 2023 | 21.10% |
| Q3 2023 | 7.03% |
| Q2 2023 | -12.60% |
| Q1 2023 | -365.34% |
| Q4 2022 | 80.86% |
| Q3 2022 | 16.59% |
| Q2 2022 | 23.67% |
| Q1 2022 | -10.91% |
| Q4 2021 | -127.70% |
| Q3 2021 | 80.76% |
| Q2 2021 | -42743.56% |
| Q1 2021 | 11.12% |
| Q4 2020 | 0.00% |